Tingsheng Technology

Tingsheng Technology (霆升科技) is a Qiming Venture Partners portfolio company developing intracardiac echocardiography (ICE) systems — real-time imaging catheters used to guide structural heart procedures. Per Qiming's updates, its self-developed ICE diagnostic system received US FDA approval in 2025 , and its disposable TINGSN Sonic Eyes 10Pro catheter was approved by China's NMPA that same year . The system has already been used clinically in Chinese hospitals to guide procedures like atrial septal defect closure and pulmonary artery stenting , and the company was named to Zero2IPO's 2025 VENTURE50 and VBData's 2026 Future Healthcare 100 . Founding details, team, and funding history aren't covered in the available material.